AtheroClonal

Proyecto de I+D+i en líneas estratégicas.
Mutaciones somáticas y hematopoyesis clonal como factores de riesgo en aterosclerosis: del laboratorio a la clínica.

[AtheroClonal @atheroclonal]

@AtheroClonal is a public-private collaborative project funded by @CienciaGob I+D+I Líneas Estratégicas 2021. We aim to unveil the connection between somatic mutations, clonal hematopoiesis driven by these mutations and atherosclerotic cardiovascular disease. Meet the team 🧵

[Andrés Hidalgo @AndrsHidalgo16]

We are excited with our outstanding lineup of speakers, and welcoming you in Madrid for the #CNICConference #immuno_CVD in November!
Register here 👉 https://t.co/wS2HpIAbM5 🔥

@CNIC_CARDIO
@aramiro_ramiro
@SanchoLab
@PilarMartinFern

[Nuria Lopez-Bigas @nlbigas]

Our latest paper -> On identifying the mutations driving clonal hematopoiesis using machine learning models - BoostDM-CH

Great team work by @SantiDemajo, @JoanEenric, @fmuinos et al

Tweetorial 👇

[Diario Médico @diariomedico]

📢Investigadores del @CNIC_CARDIO descubren un nuevo factor de riesgo cardiovascular🫀: la hematopoyesis clonal.
➡️La colchicina es útil en las mutaciones del gen TET2.
➡️Los estudios se publican en @NatureMedicine y 'European Heart Journal'.

✍️@rocio79 https://t.co/ooKlMcpQTE

[Ivan Mendoza @mencardio]

Valentin Fuster Nuevo Factor de Riesgo Cardiovascular @ivanovich13 @SIAC_cardio @CardiologiaSVC @CNIC_CARDIO https://t.co/g6cXoTzS2t @ivanovich

[Miriam Díez @miriam_diezd]

Exploring the chicken-or-egg dilemma between clonal hematopoiesis and atherosclerosis. Our latest study, published today in @NatureMedicine (https://t.co/S26bV9zs7N), addresses this critical question. Check out the thread below ⬇️

[Fundación FIC @fundacion_fic]

🔬Un nuevo estudio publicado en @NatureMedicine y realizado por personal investigador del @CNIC_CARDIO y del @CIBER_CV, identifica el papel de la #hematopoyesisClonal en la #aterosclerosis. Para combartirlo, proponen el uso de la #colchicina

https://t.co/yqVwi6EY8Y

[Nature Medicine @NatureMedicine]

A longitudinal study finds that whereas clonal hematopoiesis confers an increased risk of #atherosclerosis, the reverse is not the case, arguing for a unidirectional effect of clonal hematopoiesis on atherosclerosis
https://t.co/ZhwDH9EBKv

[Eric Topol @EricTopol]

Two new studies on mutated blood stem cells clones, appearing frequently in our blood with aging (known as CHIP)
—strong association with atherosclerosis https://t.co/AoLS1ErTEx
—benefit of colchicine, an anti-inflammatory agent, vs atherosclerosis in mice and heart attack in @UK_Biobank participants, with TET2 CHIP
https://t.co/vlX2LvdWHi
@josejfuster @NatureMedicine @ESC_Journals @CNIC_CARDIO

[José Javier Fuster @josejfuster]

And another paper online simultaneously with #ESCCongress! With Dr. Valentin Fuster and colleagues @CNIC_CARDIO, we clarify the relationship between clonal hematopoiesis and atherosclerosis. @NatureMedicine https://t.co/4bYVH9ZBzt More details ➡️ https://t.co/ob4nfA8fku

[José Javier Fuster @josejfuster]

Now online simultaneously with #ESCCongress! Colchicine as a promising candidate to prevent atherosclerosis in TET2-mutant clonal hematopoiesis. A great collaboration with @pnatarajanmd led by @MariaAZuriaga and @ZhiYu_ACGT. https://t.co/b0HhX26elt

[Benedetta Izzi @BenedettaIzzi]

Great talk on #clonalhematopoiesis and #CVDrisk just delivered by @josejfuster at the #GTH2024 in beautiful Vienna!

[José Javier Fuster @josejfuster]

Particularly excited about research within the Atherosclerosis Program 😆: https://t.co/4TThHuT2Ub

[José Javier Fuster @josejfuster]

Interested about ongoing research at @CNIC_CARDIO? Take a look! https://t.co/taY3vyRbRC

[José Javier Fuster @josejfuster]

Interesado en la investigación que hacemos en @CNIC_CARDIO? ¡Echa un vistazo! https://t.co/uRrfZiCwxB

[José Javier Fuster @josejfuster]

Important new study in @JAMACardio linking clonal hematopoiesis to coronary artery disease in individuals with East Asian ancestry! https://t.co/L6YBg2RF6K Congrats to all authors @BennyCho8! Happy to write the accompanying editorial comment @CNIC_CARDIO : https://t.co/lrhzyi1wVw

[CNIC @CNIC_CARDIO]

@CNIC_CARDIO is offering a Postdoctoral researcher for the group Hematovascular Pathophysiology @josejfuster #cnic_empleo #SOMMaJobs More info: https://t.co/F3tivj47AM

[MyoClonal @myoclonal]

An early Holiday present! @myoclonal researchers at @IRBBarcelona used machine learning to develop a data-driven approach to distinguish mutations that drive clonal hematopoiesis from non-drivers! Available as a preprint https://t.co/05RrcZ1wmB. Tweetorial 👇🏼

[CNIC @CNIC_CARDIO]

📢❤️10 #PhD positions @FundlaCaixa Incoming INPhINIT 2023 at @CNIC_CARDIO @SaludISCIII @BecariosFLC #laCaixaFoundFellows @SOMM_alliance
More info and research lines here and this thread:👇
https://t.co/oOGcuiNUUo

[AtheroClonal @atheroclonal]

@miriam_diezd and @blrneble from @josejfuster group at @CNIC_CARDIO presented their work on somatic mutations, clonal hematopoiesis and subclinical atherosclerosis at the IV Interdisciplinary Human Genetics Congress last week, congratulations!

[Miriam Díez @miriam_diezd]

Un honor poder presentar este proyecto sobre hematopoyesis clonal y aterosclerosis subclínica en el IV Congreso Interdisciplinar de Genética Humana en Málaga @blrneble @josejfuster @BenedettaIzzi @CNIC_BioIT @UdG_CNIC
#CongresoGenética23

[Miriam Díez @miriam_diezd]

Un honor poder presentar este proyecto sobre hematopoyesis clonal y aterosclerosis subclínica en el IV Congreso Interdisciplinar de Genética Humana en Málaga @blrneble @josejfuster @BenedettaIzzi @CNIC_BioIT @UdG_CNIC
#CongresoGenética23